Cara Rosenbaum is an Oncology physician. OpenAlex indexes 89 publications with 3,366 citations (h-index 21); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave # Mc2115
Chicago, IL 606371447
Telephone
773-702-0167Registry record last updated 11 Apr 2008.
Clinical trials
- Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
Sponsor: Weill Medical College of Cornell University
- Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
Sponsor: Travera Inc
- Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- Karyopharm Therapeutics Inc.Program year20241 payment
- Rigel Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies
JCO Precision Oncology
2024 - First report of outcomes in patients with stage I<scp>IIb AL</scp> amyloidosis treated with <scp>Dara–VCD</scp> front‐line therapy
British Journal of Haematology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”